PURE Bioscience, Inc. (PURE)
OTCMKTS: PURE · Delayed Price · USD
-0.0080 (-9.41%)
May 20, 2024, 2:36 PM EDT - Market closed

Company Description

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally.

The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.

It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces.

The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds.

PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

PURE Bioscience, Inc.
Country Canada
Founded 1992
IPO Date Aug 8, 1996
Industry Household & Personal Products
Sector Consumer Staples
Employees 11
CEO Robert F. Bartlett

Contact Details

771 Jamacha Road #512
El Cajon, California 92019
United States
Phone 619-596-8600
Website purebio.com

Stock Details

Ticker Symbol PURE
Exchange OTCMKTS
Fiscal Year August - July
Reporting Currency USD
CIK Code 0001006028
CUSIP Number 74621T209
ISIN Number US74621T2096
Employer ID 33-0530289
SIC Code 2890

Key Executives

Name Position
Robert F. Bartlett President, Chief Executive Officer and Director
Mark Stuart Elliott Vice President of Finance and Principal Financial and Accounting Officer
Thomas Richard Myers Executive Vice President of Technology and Development and Director
Jeff Kitchell Vice President of Operations and Corporate Secretary
Tim Steffensmeier Vice President of Sales and Marketing

Latest SEC Filings

Date Type Title
May 7, 2024 8-K Current Report
Mar 27, 2024 8-K Current Report
Mar 18, 2024 10-Q Quarterly Report
Mar 18, 2024 8-K Current Report
Feb 26, 2024 8-K Current Report
Jan 10, 2024 DEF 14A Other definitive proxy statements
Dec 19, 2023 PRE 14A Other preliminary proxy statements
Dec 14, 2023 10-Q Quarterly Report
Dec 14, 2023 8-K Current Report
Oct 30, 2023 10-K Annual Report